Skip to main content

Advertisement

SpringerLink
Log in

Cyclin-dependent kinase 5 is associated with risk for Alzheimer’s disease in a Dutch population-based study

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Although the role of the Cdk5 protein in Alzheimer’s disease (AD) is well recognized, there have been relatively few studies investigating genetic variants in the CDK5 gene in AD. In this study, we assessed the association between five previously described single nucleotide polymorphisms (SNPs) in the CDK5 gene and late onset AD by means of logistic regression and haplotype association analyses. Including all prevalent and incident AD cases, we found a significantly increased risk of AD for carriers of the GG genotype of SNP rs2069442 (OR = 1.79, 95 % CI 1.16–2.79, p = 0.001) in those without APOE*4. When limiting the analysis to incident cases without APOE*4, carriers of the GG genotype showed a 1.9-fold increased risk of AD (95 % CI 1.16–3.10, p = 0.003). Variations in the CDK5 gene can be described in 5 haplotype blocks. In our analysis, the haplotype tagged by the G allele of SNP rs2069442 was significantly associated with AD (p = 0.05). In conclusion, our study suggests that CDK5 may be associated with AD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lee MS, Tsai LH (2003) Cdk5: One of the links between senile plaques and neurofibrillary tangles? J Alzheimers Dis 5(2):127–137

    PubMed  CAS  Google Scholar 

  2. Cruz JC, Tseng HC, Goldman JA, Shih H, Tsai LH (2003) Aberrant Cdk5 activation by P25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40(3):471–483

    Article  PubMed  CAS  Google Scholar 

  3. Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH (1999) Conversion of P35 to P25 Deregulates Cdk5 Activity and Promotes Neurodegeneration. Nature 402(6762):615–622

    Article  PubMed  CAS  Google Scholar 

  4. Lew J, Winkfein RJ, Paudel HK, Wang JH (1992) Brain Proline-Directed Protein Kinase Is a Neurofilament Kinase Which Displays High Sequence Homology to P34cdc2. J Biol Chem 267(36):25922–25926

    PubMed  CAS  Google Scholar 

  5. Meyerson M, Enders GH, Wu CL, Su LK, Gorka C, Nelson C, Harlow E, Tsai LH (1992) A Family of Human Cdc2- Related Protein Kinases. Embo J 11(8):2909–2917

    PubMed  CAS  Google Scholar 

  6. Li BS, Sun MK, Zhang L, Takahashi S, Ma W, Vinade L, Kulkarni AB, Brady RO, Pant HC (2001) Regulation of Nmda Receptors by Cyclin-Dependent Kinase-5. Proc Natl Acad Sci USA 98(22):12742–12747

    Article  PubMed  CAS  Google Scholar 

  7. Lund ET, McKenna R, Evans DB, Sharma SK, Mathews WR (2001) Characterization of the in Vitro Phosphorylation of Human Tau by Tau Protein Kinase Ii (Cdk5/P20) Using Mass Spectrometry. J Neurochem 76(4):1221–1232

    Article  PubMed  CAS  Google Scholar 

  8. Cheung ZH, Fu AK, Ip NY (2006) Synaptic Roles of Cdk5: Implications in Higher Cognitive Functions and Neurodegenerative Diseases. Neuron 50(1):13–18

    Article  PubMed  CAS  Google Scholar 

  9. Cruz JC, Tsai LH (2004) Cdk5 Deregulation in the Pathogenesis of Alzheimer’s Disease. Trends Mol Med 10(9):452–458

    Article  PubMed  CAS  Google Scholar 

  10. Fischer A, Sananbenesi F, Pang PT, Lu B, Tsai LH (2005) Opposing Roles of Transient and Prolonged Expression of P25 in Synaptic Plasticity and Hippocampus- Dependent Memory. Neuron 48(5):825–838

    Article  PubMed  CAS  Google Scholar 

  11. Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH (2000) Neurotoxicity Induces Cleavage of P35 to P25 by Calpain. Nature 405(6784):360–364

    Article  PubMed  CAS  Google Scholar 

  12. Liu F, Su Y, Li B, Zhou Y, Ryder J, Gonzalez- DeWhitt P, May PC, Ni B (2003) Regulation of Amyloid Precursor Protein (App) Phosphorylation and Processing by P35/Cdk5 and P25/Cdk5. FEBS Lett 547(1–3):193–196

    Article  PubMed  CAS  Google Scholar 

  13. Nakamura S, Kawamoto Y, Nakano S, Ikemoto A, Akiguchi I, Kimura J (1997) Cyclin-Dependent Kinase 5 in Lewy Body-Like Inclusions in Anterior Horn Cells of a Patient with Sporadic Amyotrophic Lateral Sclerosis. Neurology 48(1):267–270

    PubMed  CAS  Google Scholar 

  14. Shelton SB, Johnson GV (2004) Cyclin- Dependent Kinase-5 in Neurodegeneration. J Neurochem 88(6):1313–1326

    Article  PubMed  CAS  Google Scholar 

  15. Han P, Dou F, Li F, Zhang X, Zhang YW, Zheng H, Lipton SA, Xu H, Liao FF (2005) Suppression of Cyclin-Dependent Kinase 5 Activation by Amyloid Precursor Protein: A Novel Excitoprotective Mechanism Involving Modulation of Tau Phosphorylation. J Neurosci 25(50):11542–11552

    Article  PubMed  CAS  Google Scholar 

  16. Bertram L, Mullin K, Blacker D, Tanzi R (2007) Http://www. Alzgene. Org Accessed: March 2007

    Google Scholar 

  17. Rademakers R, Sleegers K, Theuns J, Van den Broeck M, Bel Kacem S, Nilsson LG, Adolfsson R, van Duijn CM, Van Broeckhoven C, Cruts M (2005) Association of Cyclin-Dependent Kinase 5 and Neuronal Activators P35 and P39 Complex in Early-Onset Alzheimer’s Disease. Neurobiol Aging 26(8):1145–1151

    Article  PubMed  CAS  Google Scholar 

  18. Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA (1991) Determinants of Disease and Disability in the Elderly: The Rotterdam Elderly Study. Eur J Epidemiol 7(4):403–422

    Article  PubMed  CAS  Google Scholar 

  19. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM (2003) Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline. N Engl J Med 348(13):1215–1222

    Article  PubMed  Google Scholar 

  20. Barendregt JJ, Ott A (2005) Consistency of Epidemiologic Estimates. Eur J Epidemiol 20(10):827–832

    Article  PubMed  Google Scholar 

  21. Folstein MF, Folstein SE, McHugh PR (1975) “Mini-Mental State”. A Practical Method for Grading the Cognitive State of Patients for the Clinician. J Psychiatr Res 12(3):189–198

    Article  PubMed  CAS  Google Scholar 

  22. Copeland JR, Kelleher MJ, Kellett JM, Gourlay AJ, Gurland BJ, Fleiss JL, Sharpe L (1976) A Semi-Structured Clinical Interview for the Assessment of Diagnosis and Mental State in the Elderly: The Geriatric Mental State Schedule. I. Development and Reliability. Psychol Med 6(3):439–449

    Article  PubMed  CAS  Google Scholar 

  23. Association AP (1987) Diagnostic and Statistical Manual of Mental Disorders

  24. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical Diagnosis of Alzheimer’s Disease: Report of the Nincds-Adrda Work Group under the Auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34(7):939–944

    PubMed  CAS  Google Scholar 

  25. Miller SA, Dykes DD, Polesky HF (1988) A Simple Salting out Procedure for Extracting DNA from Human Nucleated Cells. Nucleic Acids Res 16(3):1215

    Article  PubMed  CAS  Google Scholar 

  26. Wenham PR, Price WH, Blandell G (1991) Apolipoprotein E Genotyping by One-Stage Pcr. Lancet 337(8750):1158–1159

    Article  PubMed  CAS  Google Scholar 

  27. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: Analysis and Visualization of Ld and Haplotype Maps. Bioinformatics 21(2):263–265

    Article  PubMed  CAS  Google Scholar 

  28. Schaid DJ (2005) Haplo. Stats: Statistical Analysis of Haplotypes with Traits and Covariates When Linkage Phase Is Ambiguous. R Package Version 1. 2. 2. http://mayoresearch. mayo. edu/mayo/ research/biostat/schaid. cfm

  29. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA (2002) Score Tests for Association between Traits and Haplotypes When Linkage Phase Is Ambiguous. Am J Hum Genet 70(2):425–434

    Article  PubMed  Google Scholar 

  30. Guo Q (2006) When good Cdk5 turns bad. Sci Aging Knowledge Environ 2006(5):pe5

    Article  PubMed  Google Scholar 

  31. Paudel HK, Lew J, Ali Z, Wang JH (1993) Brain Proline-Directed Protein Kinase Phosphorylates Tau on Sites That Are Abnormally Phosphorylated in Tau Associated with Alzheimer’s Paired Helical Filaments. J Biol Chem 268(31):23512–23518

    PubMed  CAS  Google Scholar 

  32. Hanger DP, Hughes K, Woodgett JR, Brion JP, Anderton BH (1992) Glycogen Synthase Kinase-3 Induces Alzheimer’s Disease-Like Phosphorylation of Tau: Generation of Paired Helical Filament Epitopes and Neuronal Localisation of the Kinase. Neurosci Lett 147(1):58–62

    Article  PubMed  CAS  Google Scholar 

  33. Ishiguro K, Takamatsu M, Tomizawa K, Omori A, Takahashi M, Arioka M, Uchida T, Imahori K (1992) Tau Protein Kinase I Converts Normal Tau Protein into A68-Like Component of Paired Helical Filaments. J Biol Chem 267(15):10897–10901

    PubMed  CAS  Google Scholar 

  34. Mandelkow EM, Drewes G, Biernat J, Gustke N, Van Lint J, Vandenheede JR, Mandelkow E (1992) Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. FEBS Lett 314(3):315–321

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Genetic Epidemiology Unit, Dept. of Epidemiology & Biostatistics and Dept. of Clinical Genetics, Erasmus Medical Center, 2040, 3000, CA Rotterdam, The Netherlands

    A. Arias-Vásquez, Y. S. Aulchenko, A. Isaacs, A. van Oosterhout, A. Hofman, B. A. Oostra, M. Breteler & C. M. van Duijn

  2. Neurodegenerative Brain Diseases Group, Dept. of Molecular Genetics, VIB, Antwerpen, Belgium

    K. Sleegers & C. van Broeckhoven

  3. University of Antwerp, Antwerpen, Belgium

    K. Sleegers & C. van Broeckhoven

Authors
  1. A. Arias-Vásquez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y. S. Aulchenko
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Isaacs
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. van Oosterhout
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. Sleegers
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Hofman
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C. van Broeckhoven
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. B. A. Oostra
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M. Breteler
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. C. M. van Duijn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Arias-Vásquez.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arias-Vásquez, A., Aulchenko, Y.S., Isaacs, A. et al. Cyclin-dependent kinase 5 is associated with risk for Alzheimer’s disease in a Dutch population-based study. J Neurol 255, 655–662 (2008). https://doi.org/10.1007/s00415-008-0770-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-008-0770-5

Key words

Search

Navigation